Home » Newsletters » BioWorld Science

BioWorld Science

April 18, 2019

View Archived Issues

Herpes vaccine prevents dam-pup transmission

Helicase is synthetic lethal with MSI

PROZ gene variants linked to new autosomal recessive thrombophilia

Rigel Pharmaceuticals patents TAM receptor tyrosine kinase inhibitors

Guangzhou Yuemei Pharmaceutical Technology patents globo H antigen cancer vaccine

Agency for Defense Development of Korea discloses antibodies against botulinum toxin type A

Nihon Pharmaceutical and Niigata University present liver integrated bone marrow-derived stem cells

5-HT7/5-HT1A partial agonist FPT shows promise in model of fragile X syndrome

First patient dosed in a phase I study of IBI-302 for the treatment of wet AMD

EMT inhibitor C-150 suppresses pancreatic tumor growth in vivo

SK Biopharmaceuticals and twoXAR collaborate to discover and develop first-in-class drugs for NSCLC

Novel ovario-hysterectomy-induced rabbit model of postmenopausal osteoporosis

microRNA-126 as novel circulating biomarker of vascular dysfunction in ANCA vasculitis

ODM-207 shows antitumor activity in ER+ breast cancer models

GenSight Biologics reports positive week 72 results from phase III RESCUE study of GS-010

PureTech and Boehringer to develop immune-oncology candidates using lymphatic targeting platform

Phase Ia data presented for hepatitis B candidate ABI-H2158

Celgene initiates phase I/II study of CC-90011 in extensive-stage small-cell lung cancer

Antitumor compound SRX-3207 inhibits both tyrosine-protein kinase SYK and PI3K

Yale scientists restore function in pig brains post-mortem

First-in-human study of F-520 recruiting participants

COBRA molecule MVC-101 targets CD3, EGFR for antitumor activity

Promising phase II data announced for novel allogeneic cell therapy, FCR-001

Enrollment ongoing in phase II study of p53MVA in combination with pembrolizumab

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...